YOGESH PATEL: Open Payments
NPI 1346765666 · MAGNA, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 33 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $577 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $236 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $94 |
| Novo Nordisk Inc | 5 | $80 |
| Indivior Inc. | 2 | $58 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Lundbeck LLC | 1 | $29 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $24 |
| Lilly USA, LLC | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
Products named: VRAYLAR, CAPLYTA, SUBLOCADE, BREZTRI, Wegovy, REXULTI, JOURNAVX, VERQUVO.
Industry payments across UT — which companies pay providers there.
